Deals Shaping The Medical Industry, September 2022
Executive Summary
In Vivo's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2022. Data provided by Biomedtracker.
You may also be interested in...
Oxford Biodynamics Releases EpiSwitch Prostate Cancer Test Early
The UK-based company is hoping to quickly take market share with its blood-based diagnostic that uses epigenetic data to assist cancer diagnosis.
Minute Insight: Virtual Incision Draws In Another $30m With Its Table-Top Surgical Robot
The cash will be used to extend the company’s development runway “well into 2025.”
Snapshot: August Highlights
A selection of articles you may have missed from August 2023, including a breakdown of CEO pay, a discussion on being out and proud in the life sciences sector, and some hopeful discourse on the investment landscape going into 2024.